BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10096096)

  • 1. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
    Hilliard B; Ventura ES; Rostami A
    Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
    Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
    Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
    al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
    Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
    Pope L; Paterson PY; Miller SD
    J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
    Popovich PG; Yu JY; Whitacre CC
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-driven bystander suppression after oral administration of antigens.
    Miller A; Lider O; Weiner HL
    J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
    Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
    J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
    Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
    Bioorg Med Chem; 2000 Aug; 8(8):1903-9. PubMed ID: 11003134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.
    Xiao BG; Huang YM; Yang JS; Xu LY; Link H
    Clin Exp Immunol; 2001 Aug; 125(2):300-9. PubMed ID: 11529923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
    Bouwer HG; Hinrichs DJ
    J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
    Miller A; Lider O; Abramsky O; Weiner HL
    Eur J Immunol; 1994 May; 24(5):1026-32. PubMed ID: 7514126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog.
    Stepaniak JA; Gould KE; Swanborg RH
    J Neurosci Res; 1996 Aug; 45(4):447-54. PubMed ID: 8872905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.